Errors in Landmark Stem Cell Paper

A study demonstrating the production of human stem cells through cloning contained several mislabeled images, but the authors insist the results are real.

Written byDan Cossins
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Shoukhrat MitalipovOREGON HEALTH AND SCIENCE UNIVERSITYThe team behind a landmark study published last week that reported the creation of human embryonic stem cells via nuclear transfer, or cloning, has admitted that several images in paper were duplicated or mislabeled, but insists the errors do not invalidate the results, reported Nature.

“The results are real, the cell lines are real, everything is real,” Shoukhrat Mitalipov of the Oregon Health and Science University, who led the study, told Nature. Mitalipov also explained that the unusually rapid review of the paper, which was accepted 4 days after submission and published just 12 days later, was a result of his eagerness to present the results at a meeting in June.

The research, published in Cell, was the first time stem cells had been generated via nuclear transfer, the same achievement claimed by Korean scientists in 2004 in what turned out to be a notorious case of scientific fraud. So alarm bells were ringing when a day after publication a commenter of the website PubPeer alleged that Mitalipov’s paper contained ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies